Cargando…
The deubiquitinating enzyme OTUD1 antagonizes BH3-mimetic inhibitor induced cell death through regulating the stability of the MCL1 protein
BACKGROUND: Myeloid cell leukaemia 1 (MCL1) is a pro-survival Bcl-2 family protein that plays important roles in cell survival, proliferation, differentiation and tumourigenesis. MCL1 is a fast-turnover protein that is degraded via an ubiquitination/proteasome-dependent mechanism. Although several E...
Autores principales: | Wu, Lanqin, Lin, Yingying, Feng, Jinan, Qi, Yuanlin, Wang, Xinrui, Lin, Qiaofa, Shi, Wanyan, Zheng, Enrun, Wang, Wei, Hou, Zhenzhu, Lin, Hanbin, Yu, Cheng, He, Yan, Xu, Yan, Yang, Hong, Lin, Ling, Li, Lisheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712616/ https://www.ncbi.nlm.nih.gov/pubmed/31467488 http://dx.doi.org/10.1186/s12935-019-0936-5 |
Ejemplares similares
-
Low carbohydrate diet prevents Mcl-1-mediated resistance to BH3-mimetics
por: Rubio-Patiño, Camila, et al.
Publicado: (2016) -
OTUD4-mediated GSDME deubiquitination enhances radiosensitivity in nasopharyngeal carcinoma by inducing pyroptosis
por: Di, Muping, et al.
Publicado: (2022) -
OTUD7B suppresses Smac mimetic-induced lung cancer cell invasion and migration via deubiquitinating TRAF3
por: Zhang, Boxiang, et al.
Publicado: (2020) -
Breast cancer metastasis suppressor OTUD1 deubiquitinates SMAD7
por: Zhang, Zhengkui, et al.
Publicado: (2017) -
First MCL-1-selective BH3 mimetics as potential therapeutics for targeted treatment of cancer
por: Besbes, S, et al.
Publicado: (2015)